1.Treatment and Diagnosis of Osteoporosis.
Journal of the Korean Neurological Association 2017;35(Suppl):20-24
Osteoporosis is a skeletal disorder characterized by a compromised bone strength and an increased risk of fracture. Older women with low bone mineral density (BMD) have a higher prevalence of atherosclerotic vascular disease (coronary artery disease, ischemic stroke, or peripheral arterial disease) than older women with normal BMD. Also stroke is frequently followed by extensive bone loss, precipitating the increased fracture risk in survivors. Complications from fractures lead to increased morbidity and mortality. In this paper, the clinical evidence, diagnosis and treatments of osteoporosis will be reviewed.
Arteries
;
Bone Density
;
Diagnosis*
;
Female
;
Humans
;
Mortality
;
Osteoporosis*
;
Prevalence
;
Stroke
;
Survivors
;
Vascular Diseases
2.The Relationship between Subclinical Thyroid Disease and Cardiovascular Disease Risk Score in Koreans.
Hee Joong LIM ; Seong Hee AHN ; Seongbin HONG ; Young Ju SUH
Journal of Korean Medical Science 2017;32(10):1626-1632
Subclinical hyperthyroidism and subclinical hypothyroidism are characterized by abnormal thyroid stimulating hormone (TSH) with normal free thyroxine. Subclinical thyroid diseases, to date, have received less attention compared with other thyroid diseases since they are asymptomatic. This study aimed to verify the association between subclinical thyroid diseases and cardiovascular diseases (CVDs) risk score in the Korean population. This was a population-based cohort study using data collected from 3,722 subjects (aged ≥ 30 years) during the 6th Korea National Health and Nutrition Examination Survey (KNHANES VI; 2013–2015). Gender-specific Framingham risk scores were calculated to identify the association between subclinical thyroid diseases and 10-year CVD risk score. Complex survey, with consideration of sampling weight, was analyzed using generalized linear models after stratification by gender. The TSH reference range was between 0.61 and 6.91 mIU/L in this study. TSH showed a positive association with the 10-year CVD risk score only in the female population (P = 0.001). There were significant differences in the least squares means of 10-year CVD risk score by the effect of subclinical hypothyroidism compared with euthyroidism (normal group) in females, after adjusting for body mass index, white blood cell, and urine iodine (P = 0.006 and Bonferroni corrected P = 0.012). In conclusion, subclinical hypothyroidism is associated with increased 10-year CVD risk score in the female Korean population aged 30 years or more. Therefore, we recommend to clinically checkup major CVD risk factors in female patients with subclinical hypothyroidism aged 30 years or more.
Body Mass Index
;
Cardiovascular Diseases*
;
Cohort Studies
;
Female
;
Humans
;
Hyperthyroidism
;
Hypothyroidism
;
Iodine
;
Korea
;
Least-Squares Analysis
;
Leukocytes
;
Linear Models
;
Nutrition Surveys
;
Reference Values
;
Risk Factors
;
Thyroid Diseases*
;
Thyroid Gland*
;
Thyrotropin
;
Thyroxine
3.Recent Advances in Management of Cancer Treatment-induced Bone Loss (CTIBL) in Patients with Breast or Prostate Cancer.
Soo Hyun KIM ; Seongbin HONG ; Youngkyu SONG ; Hosook SONG
Asian Oncology Nursing 2013;13(3):103-112
PURPOSE: Bone loss resulting from cancer treatment is an emerging problem among cancer survivors. However, the mechanism and treatment of cancer treatment-induced bone loss (CTIBL) is not fully understood. The purpose of this article was to review the recent advances in CTIBL. METHODS: A comprehensive review of the literature was conducted. RESULTS: Risk factors for CTIBL that are unique to or commonly found in cancer survivors include chemotherapy-induced menopause, anti-estrogen and anti-androgen therapies, gonadotropin-releasing hormone suppression of gonadal function, and use of glucocorticoids. Assessment of CTIBL is performed using dual X-ray absorptiometry testing for measurement of BMD levels, Fracture Risk Assessment Tool, and bone turnover markers. Initial strategies for prevention of CTIBL include lifestyle modifications such as exercise, an adequate intake of calcium and vitamin D, avoiding tobacco use, and limiting alcohol intake. Pharmacologic therapy should be considered for patients at high risk for bone loss or fracture. CONCLUSIONS: Prevention of CTIBL may be the best way to decrease morbidity and financial costs associated with osteoporosis and/or fractures. Oncology nurses should be well prepared to identify cancer survivors at risk of CTIBL, and to provide them with education regarding prevention and treatment of CTIBL.
Absorptiometry, Photon
;
Breast Neoplasms
;
Breast*
;
Calcium
;
Education
;
Female
;
Fractures, Bone
;
Glucocorticoids
;
Gonadotropin-Releasing Hormone
;
Gonads
;
Health Promotion
;
Humans
;
Life Style
;
Menopause
;
Osteoporosis
;
Prostate*
;
Prostatic Neoplasms*
;
Risk Assessment
;
Risk Factors
;
Survivors
;
Tobacco
;
Vitamin D
4.Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Preserved Renal Function
Da Hea SEO ; Moonsuk NAM ; Mihye JUNG ; Young Ju SUH ; Seong Hee AHN ; Seongbin HONG ; So Hun KIM
Diabetes & Metabolism Journal 2020;44(S1):e37-
Background:
Recent studies have demonstrated that the levels of adipocyte fatty acid-binding protein (A-FABP) are closely associated with diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). This study aimed to examine the association between serum A-FABP level and rapid renal function decline in patients with T2DM and preserved renal function.
Methods:
This was a prospective observational study of 452 patients with T2DM and preserved renal function who had serial measurements of estimated glomerular filtration rate (eGFR). Rapid renal function decline was defined as an eGFR decline of >4% per year. The association between baseline serum A-FABP level and rapid renal function decline was investigated.
Results:
Over a median follow-up of 7 years, 82 participants (18.1%) experienced rapid renal function decline. Median A-FABP levels were significantly higher in patients with rapid renal function decline, compared to non-decliners (20.2 ng/mL vs. 17.2 ng/ mL, P=0.005). A higher baseline level of A-FABP was associated with a greater risk of developing rapid renal function decline, independent of age, sex, duration of diabetes, body mass index, systolic blood pressure, history of cardiovascular disease, baseline eGFR, urine albumin creatinine ratio, total cholesterol, glycosylated hemoglobin, high-sensitivity C-reactive protein and use of thiazolidinedione, insulin, angiotensin-converting-enzyme inhibitors and angiotensin II-receptor blockers and statin (odds ratio, 3.10; 95% confidence interval, 1.53 to 6.29; P=0.002).
Conclusion
A high level of serum A-FABP is associated with an increased risk of rapid renal function decline in patients with T2DM and preserved renal function. This suggests that A-FABP could play a role in the progression of DKD in the early stages.
5.Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Preserved Renal Function
Da Hea SEO ; Moonsuk NAM ; Mihye JUNG ; Young Ju SUH ; Seong Hee AHN ; Seongbin HONG ; So Hun KIM
Diabetes & Metabolism Journal 2020;44(6):875-886
Recent studies have demonstrated that the levels of adipocyte fatty acid-binding protein (A-FABP) are closely associated with diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). This study aimed to examine the association between serum A-FABP level and rapid renal function decline in patients with T2DM and preserved renal function. This was a prospective observational study of 452 patients with T2DM and preserved renal function who had serial measurements of estimated glomerular filtration rate (eGFR). Rapid renal function decline was defined as an eGFR decline of >4% per year. The association between baseline serum A-FABP level and rapid renal function decline was investigated. Over a median follow-up of 7 years, 82 participants (18.1%) experienced rapid renal function decline. Median A-FABP levels were significantly higher in patients with rapid renal function decline, compared to non-decliners (20.2 ng/mL vs. 17.2 ng/mL, A high level of serum A-FABP is associated with an increased risk of rapid renal function decline in patients with T2DM and preserved renal function. This suggests that A-FABP could play a role in the progression of DKD in the early stages.
6.Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.
Chei Won KIM ; Seokbo HONG ; Se Hwan OH ; Jung Jin LEE ; Joo Young HAN ; Seongbin HONG ; So Hun KIM ; Moonsuk NAM ; Yong Seong KIM
Journal of Bone Metabolism 2015;22(3):135-141
Untreated hyperthyroidism and high-dose thyroid hormone are associated with osteoporosis, and increased bone mineral density (BMD) has been demonstrated in postmenopausal females with hypoparathyroidism. Studies on the effect of suppressive levothyroxine (LT4) therapy on BMD and bone metabolism after total thyroidectomy in patients with differentiated thyroid carcinoma have presented conflicting results, and few studies in relation to the status of hypoparathyroidism have been studied. One hundred postmenopausal women and 24 premenopausal women on LT4 suppression therapy were included in this study. BMD of lumbar spine and femur and bone turnover markers were measured at the baseline and during the follow-up period up to 18 months using dual energy X-ray absorptiometry. Biochemical marker of bone resorption was measured by urine deoxypyridinoline and bone formation by serum osteocalcin. The age ranged from 36 to 64 years old. Thyroid stimulating hormone (TSH) was suppressed during the study. The results showed that BMD of femur and lumbar spine were not significantly changed in both pre- and postmenopausal women except femur neck in postmenopausal women without hypoparathyroidism. Patients with hypoparathyroidism had higher BMD gain than those without hypoparathyroidism in total hip (1.25 vs. -1.18%, P=0.015). Biochemical markers of bone turnover, serum osteocalcin, and urine deoxypyridinoline did not show significant change. In conclusion, patients with well differentiated thyroid carcinoma are not at a great risk of bone loss after LT4 suppressive therapy. The state of hypoparathyroidism is associated with increased BMD, particularly in postmenopausal women.
Absorptiometry, Photon
;
Biomarkers*
;
Bone Density*
;
Bone Resorption
;
Female
;
Femur
;
Femur Neck
;
Follow-Up Studies
;
Hip
;
Humans
;
Hyperthyroidism
;
Hypoparathyroidism
;
Metabolism
;
Osteocalcin
;
Osteogenesis
;
Osteoporosis
;
Postmenopause
;
Spine
;
Thyroid Gland*
;
Thyroid Neoplasms*
;
Thyroidectomy
;
Thyrotropin
;
Thyroxine*
7.Relationship between Bone Mineral Density, Erythropoiesis, and Calcium-Phosphorus-Parathyroid Hormone Status in End-stage Renal Disease Patients.
Yoon ju OH ; Seongbin HONG ; Kyungsun MIN ; Joon Ho SONG ; Seung Youn LEE ; So Hun KIM ; Moonsuk NAM ; Yong Seong KIM
Korean Journal of Bone Metabolism 2011;18(2):93-99
OBJECTIVES: Abnormal bone turnover and mineralization is the characteristic of the end-stage renal disease (ESRD) patients receiving dialysis treatment. Reduced bone mineral density (BMD) has been reported in ESRD patients in many recent studies. Recent study has demonstrated hypoxia increases the loss of bone mass whereas the use of erythropoietin (EPO) increases bone marrow mesenchymal stem cell in vitro, which is the commonly found in ESRD patients. The objective of the present study is to analyze the relationship between erythropoiesis and calcium, phosphorus, parathyroid hormone (PTH) status in ESRD patients. METHODS: This study was a cross-sectional analysis of 183 ESRD patients (78 males, 105 females) on dialysis with mean age of 52 +/- 13 years and mean dialysis duration of 3.4 +/- 3.0 years. Duration and dose of EPO administration, hemoglobin, serum ferritin, and iron were checked in all subjects. BMD was evaluated by DXA. RESULTS: Age was negatively, and body weight and c-calcium positively associated with spine and femur neck and total hip BMD. Hemoglobin was positively correlated with femur neck and total hip BMD. Total dose of EPO, iPTH, and alkaline phosphatase had no significant association with BMD. However, according to tertile of serum PTH concentration, BMD were worst in third tertile group. In multivariate linear regression analysis, age, weight, and serum PTH affect BMD. CONCLUSIONS: BMD was independently related with age and weight. Hemoglobin correlated positively with femur neck and total hip BMD. However, treatment with EPO had no association with BMD. Increased PTH was related with reduced BMD.
Alkaline Phosphatase
;
Anoxia
;
Body Weight
;
Bone Density
;
Bone Marrow
;
Calcium
;
Cross-Sectional Studies
;
Dialysis
;
Erythropoiesis
;
Erythropoietin
;
Femur Neck
;
Ferritins
;
Hemoglobins
;
Hip
;
Humans
;
Iron
;
Kidney Failure, Chronic
;
Linear Models
;
Male
;
Mesenchymal Stromal Cells
;
Parathyroid Hormone
;
Phosphorus
;
Spine
8.Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome.
Min Ju KIM ; Ju Young HAN ; Jun Young SHIN ; Shin Il KIM ; Jeong Min LEE ; Seongbin HONG ; So Hun KIM ; Moon Suk NAM ; Yong Seong KIM
Endocrinology and Metabolism 2015;30(1):78-83
BACKGROUND: Metformin is considered the first choice oral treatment for type 2 diabetes patients in the absence of contraindications. Rarely, life-threatening complications associated with metformin treatment are seen in some patients with underlying diseases. The aim of this study was to further investigate the clinical profiles and risk factors for metformin-associated lactic acidosis (MALA) and the treatment modalities according to survival. METHODS: To identify MALA, we performed a retrospective study in seven diabetic patients who were taking metformin and had been diagnosed with lactic acidosis at Inha University Hospital between 1995 and 2012. For each patient, we recorded the age, sex, daily metformin dosage, laboratory test results, admission diagnosis, and risk factors. Also, concurrent conditions, treatment modalities, and outcomes were evaluated. RESULTS: Six patients had risk factors for lactic acidosis before admission. All patients had renal impairment on admission as a precipitating risk factor. Five patients survived and two patients died despite early renal replacement therapy. Older patients tended to have a poorer prognosis. CONCLUSION: Renal function must be monitored in elderly type 2 diabetes mellitus patients with underlying diseases and conditions causing renal impairment who begin metformin treatment. Accurate recognition of MALA and initiation of renal replacement are essential for treatment.
Acidosis, Lactic*
;
Aged
;
Causality*
;
Diabetes Mellitus, Type 2
;
Diagnosis
;
Humans
;
Metformin
;
Prognosis
;
Renal Replacement Therapy
;
Retrospective Studies
;
Risk Factors
9.Development and Validation of a Semi-Quantitative Food Frequency Questionnaire to Assess Diets of Korean Type 2 Diabetic Patients.
Seongbin HONG ; Yunjin CHOI ; Hun Jae LEE ; So Hun KIM ; Younju OE ; Seung Youn LEE ; Moonsuk NAM ; Yong Seong KIM
Korean Diabetes Journal 2010;34(1):32-39
BACKGROUND: Our aim was to assess the validity of a semi-quantitative food frequency questionnaire (FFQ) by comparison with the 3-day diet record (DR) in patients with type 2 diabetes. METHODS: Eighty five type 2 diabetic patients (aged 33 to 70 years) from the Korean National Diabetes Program (KNDP) completed 3-day DR and FFQ. The FFQ was designed to reflect the eating pattern of Korean type 2 diabetic patients, and was based on the 2003 Korean National Health and Nutrition Examination Survey. The FFQ consists of 85 food items and 12 food groups. The validity of FFQ was assessed by comparison with the 3-day DR. RESULTS: The mean age was 49 +/- 10 years. Clinical characteristic including body weight, diabetic duration, and HbA1c were not different from the total cohort subjects (n = 1,478). There were no significant differences in the mean intake of protein, fat and calcium estimated by the FFQ and the 3-day DR. Energy and carbohydrate estimated by the FFQ were higher than those estimated by the 3-day DR. The correlation coefficient was highest for energy (r = 0.740; P < 0.00) and lowest for iron (r = 0.269; P < 0.05). The Kappa values for energy, carbohydrate, protein, fat and calcium were 0.54, 0.37, 0.36, 0.46, and 0.19, respectively. CONCLUSION: The FFQ is a reasonable instrument for assessing the intake of most macronutrients in Korean type 2 diabetes, although careful consideration is required for the food groups and nutrients for which the FFQ had low validity.
Body Weight
;
Calcium
;
Cohort Studies
;
Diabetes Mellitus, Type 2
;
Diet
;
Diet Records
;
Eating
;
Humans
;
Iron
;
Nutrition Surveys
;
Surveys and Questionnaires
10.Development and Validation of a Semi-Quantitative Food Frequency Questionnaire to Assess Diets of Korean Type 2 Diabetic Patients.
Seongbin HONG ; Yunjin CHOI ; Hun Jae LEE ; So Hun KIM ; Younju OE ; Seung Youn LEE ; Moonsuk NAM ; Yong Seong KIM
Korean Diabetes Journal 2010;34(1):32-39
BACKGROUND: Our aim was to assess the validity of a semi-quantitative food frequency questionnaire (FFQ) by comparison with the 3-day diet record (DR) in patients with type 2 diabetes. METHODS: Eighty five type 2 diabetic patients (aged 33 to 70 years) from the Korean National Diabetes Program (KNDP) completed 3-day DR and FFQ. The FFQ was designed to reflect the eating pattern of Korean type 2 diabetic patients, and was based on the 2003 Korean National Health and Nutrition Examination Survey. The FFQ consists of 85 food items and 12 food groups. The validity of FFQ was assessed by comparison with the 3-day DR. RESULTS: The mean age was 49 +/- 10 years. Clinical characteristic including body weight, diabetic duration, and HbA1c were not different from the total cohort subjects (n = 1,478). There were no significant differences in the mean intake of protein, fat and calcium estimated by the FFQ and the 3-day DR. Energy and carbohydrate estimated by the FFQ were higher than those estimated by the 3-day DR. The correlation coefficient was highest for energy (r = 0.740; P < 0.00) and lowest for iron (r = 0.269; P < 0.05). The Kappa values for energy, carbohydrate, protein, fat and calcium were 0.54, 0.37, 0.36, 0.46, and 0.19, respectively. CONCLUSION: The FFQ is a reasonable instrument for assessing the intake of most macronutrients in Korean type 2 diabetes, although careful consideration is required for the food groups and nutrients for which the FFQ had low validity.
Body Weight
;
Calcium
;
Cohort Studies
;
Diabetes Mellitus, Type 2
;
Diet
;
Diet Records
;
Eating
;
Humans
;
Iron
;
Nutrition Surveys
;
Surveys and Questionnaires